Cholecystokinin and gastrin levels are not elevated in human pancreatic adenocarcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 6, 2001, Pages 721-722

  Weinberg, David S ^a   Heyt, Gregory J ^a   Cavanagh, Mary ^a   Pitchon, David ^b   McGlynn, Katherine A ^c   London, W Thomas ^d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GASTRIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; CHOLECYSTOKININ; FEMALE; GASTRINS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS;

EID: 0034894433     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma
2. CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium
3. Closing the gastrin loop in pancreatic carcinoma: Co-expression of gastrin and its receptor in solid human pancreatic adenocarcinoma
4. Radioimmunoassay of gastrointestinal peptides in normal and abnormal states
5. A pilot trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer
6. Expression and processing of gastrin in pancreatic adenocarcinoma